Geezus - some real raging here.
let’s just see what happens next week. The rest is speculation.
for those frustrated with my comment of “priced in”, I hope it goes to $1 next week. I’ve been long for years. It’s been a journey. A tough one.
But from experience, I believe the upside of the approval is priced in, but the ability to commercialise and what that looks like post approval has not. This represents considerable further upside and it’s why I’m not selling.
Ann: Final Sofdra Labelling Discussions with FDA, page-74
-
- There are more pages in this discussion • 209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.025(7.04%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 36.0¢ | $3.158M | 8.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 141840 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 135173 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |